It is a common perception that approximately 50% of heart failure (HF) patients present with a normal or near-normal left ventricular (LV) ejection fraction ("HF with preserved systolic function"), ...
Diastolic dysfunction increasingly is recognized as an important cause of congestive heart failure (CHF). In this study, Mayo Clinic researchers surveyed a random sample of 2042 adults (age, 45 or ...
Two new studies on diastolic heart failure are starting at the German Centre for Cardiovascular Research (DZHK). They will investigate whether this form of heart failure can be better diagnosed and ...
COLUMBUS, Ohio (Ivanhoe Newswire) - Diastolic heart failure happens when the left ventricle, or the pumping chamber of a person’s heart becomes stiff, and blood can’t flow from the heart into the ...
(WNDU) - Diastolic heart failure happens when the left ventricle of a person’s heart becomes stiff. It prevents blood flow from the heart into the lungs. Now, for the first time, doctors are testing a ...
Columbus-based Ohio State University’s Richard M. Ross Heart Hospital is the first in the world to study the clinical benefits of a device used to treat diastolic heart failure. Diastolic heart ...
COLUMBUS, Oh. - Yardwork makes Cecil Hamilton happy. Until very recently, it was impossible. His legs would hurt and he was constantly out of breath. Hamilton had diastolic heart failure, or DHF. The ...
Incidence of cardiotoxicity after high cumulative dose of anthracyclines in adult patients with advanced soft tissue sarcomas: A systematic review and meta-analysis. Arterial stiffness and aortic ...
Of the estimated five million patients in the U.S. diagnosed with heart failure annually, nearly half will have heart failure with preserved ejection fraction (HFpEF). Also known as diastolic heart ...
M ore than 6 million adults in the United States have heart failure. Of these, about half have diastolic heart failure and the other half have systolic heart failure. In February 2021, the U.S. Food ...
Corvia Medical Inc. has closed $54 million in equity financing to support a confirmatory trial for its Interatrial Shunt Device, designed to reverse diastolic heart failure (HF), otherwise known as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback